HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Bizzarri Selected Research

Tacrolimus Binding Proteins (FKBP)

2/2013The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Bizzarri Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
02/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2013
1Multiple Sclerosis
02/2013
1Neoplasms (Cancer)
02/2013
1Parkinson Disease (Parkinson's Disease)
02/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2013

Drug/Important Bio-Agent (IBA)

1Tacrolimus Binding Proteins (FKBP)IBA
02/2013
1Tacrolimus Binding Protein 1A (FKBP12)IBA
02/2013